3D Instrumentation Versus Rotary Instrumentation

September 14, 2017 updated by: Radwa Sameeh Emara, Cairo University

The Effect of 3D Instrumentation Versus Rotary Instrumentation on Postoperative Pain and Bacterial Reduction in Necrotic Oval Canals: A Randomized Clinical Trial

enrollment of the patient after diagnosis, radiographic evaluation, and signing the informed consent.

allocation of the patient to either intervention or control group. After anaesthesia and access cavity, the first root canal sample will be taken. Endodontic treatment will be completed in one visit. The second root canal sample will be taken. Patients will be asked to evaluate their postoperative pain level using VAS scale at 6, 12, 24 hours, and daily up to 5 days. Patients will record the number of analgesics if any taken.

Study Overview

Status

Unknown

Conditions

Detailed Description

After diagnosing the case as asymptomatic pulp necrosis and confirming that the patient conforms to all eligibility criteria, (R.S) will enroll the patient in the study.

the operator will complete treatment of all cases in single visit as following:

  1. Anesthetizing the tooth using inferior alveolar nerve block technique
  2. Removal of Caries and/or coronal restorations completely with sterile bur and rubber dam will be applied.
  3. Preparation of access cavity using another sterile round carbide bur size 3 and Endo-z bur .
  4. (R.S) will take the preinstrumentation root canal sample (S1)
  5. Confirming the patency of the root canals using stainless steel hand K-files size #10 and #15 . Working length will be determined .
  6. In the intervention group, (R.S) will perform mechanical preparation in a 3D manner using Xp-endo Shaper single file in an endodontic motor at a speed of 800 rpm and a torque of 1 Ncm.
  7. In the control group, mechanical preparation will be done using rotary iRace files (#25/0.04, #30/0.04, and #40/0.04) at a speed of 600 rpm and a torque of 1.5 Ncm. The canal will be irrigated and recapitulated after the use of each instrument.
  8. EDTA gel will be used as a lubricant. The canals will be thoroughly irrigated using 3ml of 2.5% sodium hypochlorite.
  9. The canal will then be dried by using sterile paper points and then flushed with 5 ml of 5% sodium thiosulfate to inactivate the NaOCl. The postinstrumentation sample (S2) will be taken from the canals.
  10. Master cones will be fitted to the working length and a radiograph will be taken to ensure proper length.
  11. (R.S) will complete obturation using AdSeal resin-based root canal sealer .

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Manial
      • Cairo, Manial, Egypt, 11553
        • Faculty of oral and dental medicine - cairo university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Healthy Adult patients.
  2. Age between 20-40 years old.
  3. Males & Females.
  4. Asymptomatic necrotic mandibular premolars with or without periapical radiolucency.
  5. Normal occlusal contact with the opposing teeth.
  6. Patients accepting to participate in the study.

Exclusion criteria:

  1. Medically compromised patients
  2. Pregnant women
  3. If analgesics or antibiotics have been administrated by the patient during the past 12 hours preoperatively
  4. Patients reporting bruxism or clenching
  5. Teeth that shows:

    • Association with acute periapical abscess and swelling
    • Greater than grade I mobility or pocket depth greater than 5mm
    • No restorability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: XP-endo Shaper
The XP-endo Shaper is an innovative single instrument manufactured from Max wire. Its special ability to shift crystalline structure at body temperature in order to adapt to the root canal wall, has provided a unique instrument with the promise of anatomical shaping.
mechanical preparation in a 3D manner using Xp-endo Shaper
Other Names:
  • anatomical (3D) shaping file
Active Comparator: iRace
rotary files
rotary mechanical preparation
Other Names:
  • rotary files

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Pain
Time Frame: up to 5 days
Degree of postoperative pain will be measured by the patients using modified VAS
up to 5 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
intracanal bacterial reduction
Time Frame: 6 hours

The intra-canal bacterial count will be determined using culture technique in the microbiological department, Cairo University. Samples in RTF vials will be dispersed with vortex for 30 seconds by the laboratory technician. The RTF solution will be serially diluted one-tenth dilution and spiral plated onto the agar medium. The plates will be incubated at 37ₒc aerobically and anaerobically.

The resultant anaerobic growth will be quantified by evaluating the colony forming units (CFU) on the agar medium under the microscope and the number of CFU per milliliter of each dilution will be calculated for each sample.

6 hours
Incidence of analgesic intake
Time Frame: up to 5 days
In case of presence of moderate or severe postoperative pain, (R.S) will instruct the patients to take only one capsule of placebo given to him/her at the end of the visit (Powdered milk packed in opaque capsules)
up to 5 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Radwa Emara, Faculty of oral and dental medicine - cairo university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2017

Primary Completion (Anticipated)

February 1, 2018

Study Completion (Anticipated)

November 1, 2018

Study Registration Dates

First Submitted

September 13, 2017

First Submitted That Met QC Criteria

September 14, 2017

First Posted (Actual)

September 18, 2017

Study Record Updates

Last Update Posted (Actual)

September 18, 2017

Last Update Submitted That Met QC Criteria

September 14, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • CEBD-CU-2017-09-19

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on XP-endo Shaper

Subscribe